Figure 2: Crude mortality risk for any follow-up period in the first 6 months after discharge, all studies.
Data from our unpublished study, Zucker 1996,43 and Opoka, 201617 are included in more than one subgroup, each representing a mutually exclusive group. The malaria studies did not include any post-discharge chemoprophylaxis groups. Summary statistics are not shown because of considerable heterogeneity (overall I2 is 95·5%) between and within admission health-condition groups.